Maravai LifeSciences Holdings Inc at KeyBanc Capital Markets Life Sciences & MedTech Forum (Virtual) Transcript
It's Paul Knight, analyst at KeyBanc on the life science industry. With us today is Brian Neel, Chief Operating Officer of Maravai. We appreciate your time today, Brian. And I thought if we could just start with going over your background and what you're doing at Maravai.
Yes. Absolutely. Maravai LifeSciences is actually a business that has several brands within it. One of those brands I think we're going to focus on today is TriLink BioTechnologies. And at TriLink, we specialize really in 2 key areas. We have a technology that we've invested quite heavily in the last few years, a CleanCap technology, which is a capping reagent we use for mRNA production. We also have other products that we sell along with the CleanCap as a stand-alone product.
The second part of our business is a CDMO business that's very focused on mRNA API development production, specifically right now for
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |